Company / Total Assets
Dyne Therapeutics, Inc. Total Assets History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$691.2M
FY2024
5-year range
$165.1M / $691.2M
FY2020-FY2024
Trend
+318.7%
vs FY2023
Sector context
#111 of 216
Health Care
What the data says
Total Assets changed +319% YoY in FY2024, a notable deviation from the 5-year average annual change of +463%.
Based on SEC 10-K filings.
$691M in FY2024 with a 5-year CAGR of +111.2%.
Improved from $306M to $691M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +17.5%
- 5-Year CAGR
- +111.2%
- 10-Year CAGR
- -
Sector benchmark
#111 of 216 in Health CareTop 51% of 216This company $691.2M Sector average $7.4B
▼
-90.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +111.2%, indicating consistent growth.
- In FY2024, total assets increased 318.7% year-over-year.
- Ranks #111 out of 216 companies in the Health Care sector.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $691.2M | +318.7% |
| FY2023 | $165.1M | -46.1% |
| FY2022 | $306.3M | -28.0% |
| FY2021 | $425.7M | +20.5% |
| FY2020 | $353.3M | +2049.8% |
| FY2019 | $16.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026